Investment
Features
FeesSafety
Academy
More
Pluang+

Wells Fargo Series AA preferred shares rated Buy for 6.9% yield and low call risk.

Analyst Insights
15 Sep 2026
Seeking Alpha
View Source
Bullish
Wells Fargo Series AA preferred shares rated Buy for 6.9% yield and low call risk.

Wells Fargo & Company's Series AA preferred stock is rated Buy due to its attractive 6.9% yield and low risk of being called early. Despite both Series AA and Series DD being callable, current market pricing suggests a low chance of call. The dividend safety is strong, supported by a high net income-to-dividend ratio and solid equity coverage. Yields have increased by 70-80 basis points since early 2026, making them competitive with peers, though investors might want to wait if expecting a Federal Reserve rate hike.

Wells Fargo Series AA preferred stock offers an attractive yield of 6.9%, noted for its low risk of early call and strong dividend safety. For readers following the Financials sector, here is Pluang's market snapshot as of Sep 15, 2026 17:41 WIB: out of 74 priced US Financials stocks tradable on Pluang, 17 rose and 50 fell today. Notable movers include ING at USD 36.57 (-1.06%), FUTU at USD 110.10 (-0.91%), and BAC at USD 58.93 (-0.91%).

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App